This page shows the latest Pharma Mar news and features for those working in and with pharma, biotech and healthcare.
abaloparatide) and confirming its earlier rejection of Pharma Mar’s Aplidin (plitidepsin) as a treatment for multiple myeloma.
Another firm active in this space is Pharma Mar, whose marine-derived antitumoral agent Yondelis (trabectedin) received US approval last month to treat unresectable or metastic liposarcoma or leiomyosarcoma. . ... Digital inspiration for pharma on mobile
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
No results were found
Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....